HIV-1 tat inhibits NGF-induced Egr-1 transcription activity and consequent p35 expression in neural cells

Journal of Cellular Physiology

Volumn 216, Issue 1, 2008, Pages 128-134

  Darbinian, Nune ^a   Darbinyan, Armine ^a   Czernik, Marta ^a   Peruzzi, Francesca ^a   Khalili, Kamel ^a   Reiss, Krzysztof ^a   Gordon, Jennifer ^a   Amini, Shohreh ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; EARLY GROWTH RESPONSE FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROFILAMENT PROTEIN; PHOSPHOTRANSFERASE; PROTEIN P35; TRANSACTIVATOR PROTEIN; HYBRID PROTEIN; NERVE PROTEIN; NEURONAL CDK5 ACTIVATOR (P25 P35); NEURONAL CDK5 ACTIVATOR (P25-P35); SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SUPERNATANT; TRANSCRIPTION INITIATION; VIRUS INFECTION; ANIMAL; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMALS; CELL LINE; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION; HIV-1; HUMANS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; PROMOTER REGIONS (GENETICS); RATS; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION, GENETIC;

EID: 44449132173     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21382     Document Type: Article

References (60)

1. Adle-Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C, Gray F. 1995. Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 21:218-227.
2. Al-Sarraj A, Day RM, Thiel G. 2005. Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3. and Egr-1. J Cell Biochem 94:153-167.
3. Aprea S, Del Valle L, Mameli G, Sawaya BE, Khalili K, Peruzzi F. 2006. Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. J Neurosci 26:4054-4062.
4. Chapman DL, Wolgemuth DJ. 1994. Regulation of M-phase promoting factor activity during development of mouse male germ cells. Dev Biol 165:500-506.
5. Chen D, Wang M, Zhou S, Zhou Q. 2002. HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J 21:6801-6810.
6. Chen F, Wang Q, Wang X, Studzinski GP. 2004. Up-regulation of Egr-1 by 1,25-dihydroxy vitamin D3 contributes to increased expression of p35 activator of cyclin-dependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation. Cancer Res 64:5425-5433.
7. Cheung ZH, Ip NY. 2004. Cdk5: Mediator of neuronal death and survival. Neurosci Lett 361:47-51.
8. Cujec TP, Cho H, Maldonado E, Meyer J, Reinberg D, Peterlin BM. 1997. The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol Cell Biol 17:1817-1823.
9. Darbinian N, Sawaya BE, Khalili K, Jaffe N, Wortman B, Giordano A, Amini S. 2001. Functional interaction between cyclin T1/cdk9 and Puralpha determines the level of TNFalpha promoter activation by Tat in glial cells. J Neuroimmunol 121:3-11.
10. Darbinian-Sarkissian N, Czernik M, Peruzzi F, Gordon J, Rappaport J, Reiss K, Khalili K, Amini S. 2006. Dysregulation of NGF-signaling and Egr-1 expression by Tat in neuronal cell culture. J Cell Physiol 208:506-515.
11. de Mareuil J, Carre M, Barbier P, Campbell GR, Lancelot S, Opi S, Esquieu D, Watkins JD, Prevot C, Braguer D, Peyrot V, Loret EP. 2005. HIV-1 Tat protein enhances microtubule polymerization. Retrovirology 2:5.
12. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh M, Skinner MA, Valerio R. 1989. Human immunodeficiency virus I tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci USA 86:6925-6929.
13. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type I Tat protein on cell growth and viral transactivation. J Virol 67:277-287.
14. Epie N, Ammosova T, Sapir T, Voloshin Y, Lane WS, Turner W, Reiner O, Nekhai S. 2005. HIV-1 Tat interacts with LIS1 protein. Retrovirology 2:6.
15. Frankel AD, Pabo CO. 1988. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189-1193.
16. Fu WY, Chen Y, Sahin M, Zhao XS, Shi L, Bikoff JB, Lai KO, Yung WH, Fu AK, Greenberg ME, Ip NY. 2007. Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nat Neurosci 10:67-76.
17. Graham FL, van der Eb AJ. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
18. Greenberg ME, Ostapenko DA, Mathews MB. 1997. Potentiation of human immunodeficiency virus type I Tat by human cellular proteins. J Virol 71:7140-7144.
19. Harada T, Morooka T, Ogawa S, Nishida E. 2001. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr-1. Nature Cell Biol 3:453-459.
20. Hottiger MO, Nabel GJ. 1998. Interaction of human immunodeficiency virus type I Tat with the transcriptional coactivators p300 and CREB binding protein. J Virol 72:8252-8256.
21. Jeang KT, Chun R, Lin NH, Gatignol A, Glabe CG, Fan H. 1993. In vitro and in vivo binding of human immunodeficiency virus type I Tat protein and Sp1 transcription factor. J Virol 67:6224-6233.
22. Kaul M, Lipton SA. 2006. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 4:307-318.
23. Kaul M, Garden GA, Lipton SA. 2001. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988-994.
24. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA. 2005. HIV-1 infection and AIDS: Consequences for the central nervous system. Cell Death Differ 12:878-892.
25. Kawai-Kowase K, Kurabayashi M, Hoshino Y, Ohyama Y, Nagai R. 1999. Transcriptional activation of the zinc finger transcription factor BTEB2 gene by Egr-1 through mitogen-activated protein kinae pathways in vascular smooth muscle cells. Circ Res 85:787-795.
26. Kesavapany S, Li BS, Pant HC. 2003. Cyclin-dependent kinase 5 in neurofilament function and regulation. Neurosignals 12:252-264.
27. King JE, Eugenin EA, Buckner CM, Berman JW. 2006. HIV tat and neurotoxicity. Microbes Infect 8:1347-1357.
28. Lee JH, Kim KT. 2004. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells. J Neurochem 91:634-647.
29. Lee JH, Kim KT. 2007. Regulation of cyclin-dependent kinase 5 and p53 by Erk1/2 pathway in the DNA damage-induced neuronal death. J Cell Physiol 210:784-797.
30. Lees JF, Shneidman PS, Skuntz SF, Carden MJ, Lazzarini RA. 1988. The structure and organization of the human heavy neurofilament subunit (NF-H) and the gene encoding it. EMBO J 7:1947-1955.
31. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429-431.
32. Liu Y, Li J, Kim BO, Pace BS, He JJ. 2002. HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa, Tip110. J Biol Chem 277:23854-23863.
33. Ma M, Nath A. 1997. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type I in brain cells. J Virol 71:2495-2499.
34. Macho A, Calzado MA, Jimenez-Reina L, Ceballos E, Leon J, Munoz E. 1999. Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanisms. Oncogene 18:7543-7551.
35. Maggirwar SB, Tong N, Ramirez S, Gelbard HA, Dewhurst S. 1999. HIV-1 Tat mediated activation of glycogen synthase kinase-3b contributes to Tat-mediated neurotoxicity. J Neurochem 73:578-586.
36. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato J-Y. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076.
37. New DR, Ma M, Epstein LG, Nath A, Gelbard HA. 1997. Human immunodeficiency virus type I Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 3:168-173.
38. Nguyen MD, Mushynski WE, Julien JP. 2002. Cycling at the interface between neurodevelopment and neurodegeneration. Cell Death Differ 9:1294-1306.
39. Ohshima T, Kizak CA, Nagle JW, Pant HC, Brady RO, Kulkarni AB. 1996. Molecular cloning and chromosomal mapping of the mouse gene encoding cycline-dependent kinase 5 regulatory subunit p35. Genomics 35:372-375.
40. Philippon V, Vellutini C, Gambarelli D, Harkiss G, Arbuthnott G, Metzger D, Roubin R, Filippi P. 1994. The basic domain of the lentiviral Tat protein is responsible for damages in mouse brain: Involvement of cytokines. Virology 205:519-529.
41. Rolli-Derkinderen M, Machavoine F, Baraban JM, Grolleau A, Beretta L, Dy M. 2003. ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1. J Biol Chem 278:18859-18867.
42. Ross S, Tienhaara A, Lee MS, Tsai LH, Gill G. 2002. GC box-binding transcription factors control the neuronal specific transcription of the cyclin-dependent kinase 5 regulator p35. J Biol Chem 277:4455-4464.
43. Sawaya BE, Khalili K, Gordon J, Taube R, Amini S. 2000. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J Biol Chem 275:35209-35214.
44. Sharma M, Sharma P, Pant HC. 1999. CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells. J Neurochem 73:79-86.
45. Shea TB, Yabe JT, Ortiz D, Pimenta A, Loomis P, Goldman RD, Amin N, Pant HC. 2004. Cdk5 regulates axonal transport and phosphorylation of neurofilaments in cultured neurons. J Cell Sci 29:933-941.
46. Shetty KT, Link WT, Pant HC. 1993. cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: Isolation and characterisation. Proc Natl Acad Sci USA 90:6844-6848.
47. Smith D. 2003. Cdk5 in neuroskeletal dynamics. Neurosignals 12:239-251.
48. Song JH, Wang CX, Song DK, Wang P, Shuaib A, Hao C. 2005. Interferon gamma induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway. J Biol Chem 280:12896-12901.
49. Sui Z, Kovacs AD, Maggirwar SB. 2006a. Recruitment of active glycogen synthase kinase-3 into neuronal lipid rafts. Biochem Biophys Res Commun 345:1643-1648.
50. Sui Z, Sniderhan LF, Fan S, Kazmierczak K, Reisinger E, Kovacs AD, Potash MJ, Dewhurst S, Gelbard HA, Maggirwar SB. 2006b. Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons. Eur J Neurosci 23:2623-2634.
51. Tanaka T, Veeranna S, Ohshima T, Rajan P, Amin ND, Cho A, Sreenath T, Pant HC, Brady RO, Kulkarni AB. 2001. Neuronal cyclin-dependent kinase 5 activity is critical for survival. J Neurosci 21:550-558.
52. Terada M, Yasuda H, Kogawa S, Maeda K, Haneda M, Hidaka H, Khashiwagi A, Kikkawa R. 1998. Expression and activity of cyclin dependent kinase 5/p35 in adult rat peripheral nervous system. J Neurochem 71:2600-2606.
53. Thiel G, Cibelli G. 2002. Regulation of life and death by the zinc finger transcription factor, Egr-1. J Cell Physiol 193:287-292.
54. Tsai LH, Delalle I, Caviness VS Jr, Chae T, Harlow E. 1994. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419-423.
55. Tsuruda A, Suzuki S, Maekawa T, Oka S. 2004. Constitutively active Src facilitates NGF-induced phosphorylation of TrkA and causes enhancement of the MAPK signaling in SK-N-MC cells. FEBS Lett 560:215-220.
56. Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED, Mercola D. 2003. Egr-1 promotes growth and survival of prostate cancer cells. Identification of novel Egr-1 target genes. J Biol Chem 278:11802-11810.
57. Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
58. Xu Y, Kulkosky J, Acheampong E, Ninnari G, Sullivan J, Pomerantz RJ. 2004. HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy. Proc Natl Acad Sci USA 101:7070-7075.
59. Yang Y, Dong B, Mittelstadt PR, Xiao H, Ashwell JD. 2002. HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. J Biol Chem 277:19482-19487.
60. Zhang Q, Ahuja HS, Zakeri ZF, Wolgemuth DJ. 1997. Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling. Dev Biol 183:222-233.